Artificial Intelligence in Healthcare: Advancements in Kidney Disease Diagnosis and Management

Kidney diseases, particularly Chronic Kidney Disease (CKD), represent a significant and growing global health burden. CKD often progresses silently, with patients exhibiting few to no symptoms during the early stages, making timely diagnosis and intervention a critical challenge. The rising incidence of CKD, driven by factors such as diabetes, hypertension, and aging populations, necessitates the development of innovative strategies for early detection, accurate diagnosis, and effective management. Recent advancements in Artificial Intelligence (AI) have introduced transformative capabilities within the field of nephrology. AI technologies—including machine learning, deep learning, and natural language processing—are now being leveraged to enhance various aspects of renal care. These include the prediction of CKD onset and progression, automated estimation of glomerular filtration rate (GFR), image-based diagnosis through radiological and histopathological data analysis, and patient stratification for personalized treatment planning.AI-driven systems have demonstrated remarkable accuracy in identifying at-risk populations, monitoring disease progression, and facilitating clinical decision-making. Furthermore, these systems contribute to reducing human error, improving diagnostic consistency, and optimizing healthcare resource allocation. However, the integration of AI in nephrology is not without challenges. Issues such as data privacy, algorithmic bias, model interpretability, and the need for large, diverse datasets pose barriers to widespread clinical adoption. This paper provides a comprehensive review of the current state of AI applications in nephrology, examines the technologies and methodologies employed, discusses existing challenges, and explores the future directions for AI-enhanced kidney disease management. As the synergy between AI and nephrology continues to evolve, it holds the potential to revolutionize renal healthcare delivery, enabling more proactive, precise, and patient-cantered approaches.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-05-23
DOI
https://doi.org/10.5281/zenodo.15493686
Primary Topic
Artificial Intelligence in Healthcare
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial Intelligence in Healthcare: Advancements in Kidney Disease Diagnosis and Management

Zenodo (CERN European Organization for Nuclear Research)
Artificial Intelligence in Healthcare
article

Artificial Intelligence in Healthcare: Advancements in Kidney Disease Diagnosis and Management

article en

Abstract

Kidney diseases, particularly Chronic Kidney Disease (CKD), represent a significant and growing global health burden. CKD often progresses silently, with patients exhibiting few to no symptoms during the early stages, making timely diagnosis and intervention a critical challenge. The rising incidence of CKD, driven by factors such as diabetes, hypertension, and aging populations, necessitates the development of innovative strategies for early detection, accurate diagnosis, and effective management. Recent advancements in Artificial Intelligence (AI) have introduced transformative capabilities within the field of nephrology. AI technologies—including machine learning, deep learning, and natural language processing—are now being leveraged to enhance various aspects of renal care. These include the prediction of CKD onset and progression, automated estimation of glomerular filtration rate (GFR), image-based diagnosis through radiological and histopathological data analysis, and patient stratification for personalized treatment planning.AI-driven systems have demonstrated remarkable accuracy in identifying at-risk populations, monitoring disease progression, and facilitating clinical decision-making. Furthermore, these systems contribute to reducing human error, improving diagnostic consistency, and optimizing healthcare resource allocation. However, the integration of AI in nephrology is not without challenges. Issues such as data privacy, algorithmic bias, model interpretability, and the need for large, diverse datasets pose barriers to widespread clinical adoption. This paper provides a comprehensive review of the current state of AI applications in nephrology, examines the technologies and methodologies employed, discusses existing challenges, and explores the future directions for AI-enhanced kidney disease management. As the synergy between AI and nephrology continues to evolve, it holds the potential to revolutionize renal healthcare delivery, enabling more proactive, precise, and patient-cantered approaches.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 47%
Artificial Intelligence in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.